Default: European Annals of Allergy and Clinical Immunology

ISSN: 1764-1489

Journal Home

Journal Guideline

European Annals of Allergy and Clinical Immunology Q3 Unclaimed

EDRA SpA Italy
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

European Annals of Allergy and Clinical Immunology is a journal indexed in SJR in Immunology and Allergy with an H index of 36. It has an SJR impact factor of 0,521 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,521.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

European Annals of Allergy and Clinical Immunology

0,521

SJR Impact factor

36

H Index

44

Total Docs (Last Year)

123

Total Docs (3 years)

1141

Total Refs

217

Total Cites (3 years)

98

Citable Docs (3 years)

1.8

Cites/Doc (2 years)

25.93

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Atopic Dermatitis Host and Environment Model: Revisiting Therapeutic Options

View more

Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria

View more

Assessing clinical and psychological features: who are patients showing a nocebo re-action during the drug challenge test?

View more

An unusual case of positive sIgE to Galactose-alpha-1,3-galactose from South Italy

View more

Clinical aspects of hymenoptera venom allergy and venom immunotherapy

View more

Allergy and high trait anxiety are related to increases in heart rate variability: results of naturalistic long-term design study

View more

Allergy in adolescent population (14-18 years) living in Campania region (Southern Italy). A multicenter study

View more

Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab

View more

Pediatric urticaria in the Emergency Department: epidemiological characteristics and predictive factors for its persistence in children

View more

An unusual case of wheat dependent exercise induced anaphylaxis (WDEIA) triggered by Tri a 14 in a pediatric patient: a case report

View more

Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in "real life"?

View more

Evolution of Api m10 Specific IgE and IgG4 After One Year of Bee Venom Immunotherapy

View more
SHOW MORE ARTICLES

Characteristics of Patients with C1 esterase Inhibitor Deficiency: A single center study

View more

Reduction of the allergenicity of cow's milk alpha-lactalbumin under heat-treatment and enzymatic hydrolysis in Moroccan population

View more

Can concurrent lower gastrointestinal manifestations help the timely diagnosis of small intestinal bacterial overgrowth in CVID patients?

View more

Banana lectin (BanLec) induces non-specific activation of basophils and mast cells in atopic subjects

View more

Effects of omalizumab treatment on serum cytokine concentrations of atopic patients with chronic spontaneous urticaria: a preliminary report

View more

Circulating microRNAs as potential non-invasive biomarkers in pediatric patients with celiac disease

View more

Acute cardiac disease in a patient with hyper-IgE syndrome

View more

Clinical assessment of tolerability, immunological and cutaneous reactivity effects of an abbreviated schedule with Olea europaeanative extract of subcutaneous immunotherapy

View more

When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation

View more

The incidence of immunofluorescence patterns and specific autoantibodies observed in autoimmune patients in a tertiary care centre

View more

Hyperlipidemia in association with pro-inflammatory cytokines among chronic spon-taneous urticaria: case-control study

View more

Methylchloroisothiazolinone / methylisothiazolinone: epidemiological retrospective study

View more

FAQS